Device Trial Radar · NCT06184373
Early Investigation of Glucose Monitoring After Gestational Diabetes Pilot
Last checked: Nov 20, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
20
Planned (sponsor's estimate)
Start
Jun 6, 2025
Primary completion
May 30, 2027
Study completion May 30, 2027
Sponsor
- Lead sponsor
- Ohio State UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- DexCom, Inc.
- First posted
- Dec 28, 2023
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- Female only, from 18 years, up to 50 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
One third of women with gestational diabetes (GDM), diabetes diagnosed during pregnancy, have abnormal glucose levels within 3 years after pregnancy, but follow up is low. Continuous glucose monitors (CGM), a small sensor inserted under the skin, may be able to screen women with GDM for diabetes risk. The investigators will ask postpartum women to use CGM at 6-8 weeks postpartum and answer surveys about quality of life after wearing the CGM. The investigators will collect data on blood glucose trends for future studies if participants find CGM use acceptable. The investigators hope to learn if CGM could improve postpartum follow up experiences for people with recent GDM.
Conditions
- Gestational Diabetes
- Hyperglycemia
Interventions
Continuous glucose monitorDevice
CGMs will be worn for a maximum of 10 days at 6-8 weeks postpartum.
Oral Glucose Tolerance TestDiagnostic test
At 10-12 weeks postpartum, participants will complete an oral glucose tolerance test, which involves drinking a glucose substance and having glucose levels measured a maximum of 3 times.
Hemoglobin A1cDiagnostic test
At 11-14 months postpartum, participants will be asked to have their blood drawn to check their hemoglobin A1c to look for signs of developed insulin resistance
Primary outcomes
What the sponsor says the trial is designed to measure.
- Acceptability of CGMTime frame: 15 weeks from enrollment
- Comparative experience of OGTT and CGMTime frame: 15 weeks from enrollment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Ohio State University Medical Center
Columbus, Ohio · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.